Safety of Clopidogrel vs. Ticagrelor in Dual Antiplatelet Therapy Regimens for High-Bleeding Risk Acute Coronary Syndrome Patients: A Comprehensive Meta-analysis of Adverse Outcomes
ConclusionBoth drugs are generally safe for treating ACS patients with HBR at baseline, although a higher risk of MI was observed with the use of clopidogrel. Nevertheless, drug choice should factor in regional variations, patient-specific characteristics, cost, accessibility, and potential drug interactions.
Source: High Blood Pressure and Cardiovascular Prevention - Category: Cardiology Source Type: research
More News: Bleeding | Cardiology | Cardiovascular | Clopidogrel | Databases & Libraries | Heart | Heart Attack | Hypertension | Plavix | Statistics | Stroke | Study